@article{6e7a1ee7c0ff45a9b05a6c98d2fb3d5b,
title = "Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas",
keywords = "anticoagulation, atrial fibrillation, direct oral anticoagulant (DOAC), heparin, ischemic cardiovascular disease, thrombosis, venous thromboembolism (VTE), vitamin K antagonist (VKA), anticoagulation, atrial fibrillation, direct oral anticoagulant (DOAC), heparin, ischemic cardiovascular disease, thrombosis, venous thromboembolism (VTE), vitamin K antagonist (VKA)",
author = "Antonino Tuttolomondo and Pasquale Pignatelli and Roberto Pola",
year = "2023",
doi = "10.3389/fcvm.2023.1219033",
language = "English",
volume = "10",
pages = "1--3",
journal = "Frontiers in Cardiovascular Medicine",
issn = "2297-055X",
publisher = "Lausanne : Frontiers Media S.A., 2014-",
}
